393 related articles for article (PubMed ID: 15842537)
1. Long-term use of cyclosporine in the treatment of canine atopic dermatitis.
Radowicz SN; Power HT
Vet Dermatol; 2005 Apr; 16(2):81-6. PubMed ID: 15842537
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial.
Nuttall T; Mueller R; Bensignor E; Verde M; Noli C; Schmidt V; Rème C
Vet Dermatol; 2009 Jun; 20(3):191-8. PubMed ID: 19374721
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial.
Olivry T; Rivierre C; Jackson HA; Murphy KM; Davidson G; Sousa CA
Vet Dermatol; 2002 Apr; 13(2):77-87. PubMed ID: 11972891
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of cyclosporine A in cats with presumed atopic dermatitis: a double blind, randomised prednisolone-controlled study.
Wisselink MA; Willemse T
Vet J; 2009 Apr; 180(1):55-9. PubMed ID: 18294881
[TBL] [Abstract][Full Text] [Related]
5. Ciclosporin A therapy is associated with disturbances in glucose metabolism in dogs with atopic dermatitis.
Kovalik M; Thoday KL; Handel IG; Bronsvoort BM; Evans H; van den Broek AH; Mellanby RJ
Vet Dermatol; 2011 Apr; 22(2):173-80. PubMed ID: 21114560
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs.
Steffan J; Strehlau G; Maurer M; Rohlfs A
J Vet Pharmacol Ther; 2004 Aug; 27(4):231-8. PubMed ID: 15305852
[TBL] [Abstract][Full Text] [Related]
7. The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study.
Carlotti DN; Boulet M; Ducret J; Machicote G; Jasmin P; Rème CA; Albouy M
Vet Dermatol; 2009 Oct; 20(5-6):405-11. PubMed ID: 20178477
[TBL] [Abstract][Full Text] [Related]
8. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
Little PR; King VL; Davis KR; Cosgrove SB; Stegemann MR
Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
[TBL] [Abstract][Full Text] [Related]
9. Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double-blind, placebo-controlled clinical study.
Ferguson EA; Littlewood JD; Carlotti DN; Grover R; Nuttall T
Vet Dermatol; 2006 Aug; 17(4):236-43. PubMed ID: 16827666
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a human generic formulation of ciclosporin in the treatment of canine atopic dermatitis with in vitro assessment of the functional capacity of phagocytic cells.
Kovalik M; Taszkun I; Pomorski Z; Kozak M; Pomorska D; Szczepanik M; Wilkolek P; Palenik L; Shaw DJ; van den Broek AH; Thoday KL
Vet Rec; 2011 May; 168(20):537. PubMed ID: 21558130
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis.
Steffan J; Parks C; Seewald W;
J Am Vet Med Assoc; 2005 Jun; 226(11):1855-63. PubMed ID: 15934253
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a new topical cyclosporine A formulation in the treatment of atopic dermatitis in dogs.
Puigdemont A; Brazís P; Ordeix L; Dalmau A; Fuertes E; Olivar A; Pérez C; Ravera I
Vet J; 2013 Aug; 197(2):280-5. PubMed ID: 23562341
[TBL] [Abstract][Full Text] [Related]
13. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis.
Olivry T; DeBoer DJ; Favrot C; Jackson HA; Mueller RS; Nuttall T; Prélaud P;
Vet Dermatol; 2010 Jun; 21(3):233-48. PubMed ID: 20456716
[TBL] [Abstract][Full Text] [Related]
14. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis.
Nuttall TJ; McEwan NA; Bensignor E; Cornegliani L; Löwenstein C; Rème CA
Vet Dermatol; 2012 Feb; 23(1):4-10, e1-2. PubMed ID: 21718368
[TBL] [Abstract][Full Text] [Related]
15. Prednisolone is associated with an increase in serum insulin but not serum fructosamine concentrations in dogs with atopic dermatitis.
Kovalik M; Thoday KL; Evans H; van den Broek AH; Mellanby RJ
Vet J; 2012 May; 192(2):212-6. PubMed ID: 21745752
[TBL] [Abstract][Full Text] [Related]
16. Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study.
Marsella R; Nicklin CF; Saglio S; Lopez J
Vet Dermatol; 2004 Oct; 15(5):294-303. PubMed ID: 15500481
[TBL] [Abstract][Full Text] [Related]
17. Treatment of canine atopic dermatitis with cyclosporine: a pilot clinical study.
Fontaine J; Olivry T
Vet Rec; 2001 May; 148(21):662-3. PubMed ID: 11400987
[No Abstract] [Full Text] [Related]
18. The glucocorticoid sparing efficacy of Phytopica in the management of canine atopic dermatitis.
Schmidt V; McEwan N; Volk A; Helps J; Morrell K; Nuttall T
Vet Dermatol; 2010 Feb; 21(1):96-105. PubMed ID: 20187915
[TBL] [Abstract][Full Text] [Related]
19. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life.
Cosgrove SB; Cleaver DM; King VL; Gilmer AR; Daniels AE; Wren JA; Stegemann MR
Vet Dermatol; 2015 Jun; 26(3):171-9, e35. PubMed ID: 25688708
[TBL] [Abstract][Full Text] [Related]
20. A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs.
Steffan J; Favrot C; Mueller R
Vet Dermatol; 2006 Feb; 17(1):3-16. PubMed ID: 16412115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
